[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Amgen Inc (AMGN)

Amgen Inc (AMGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Mega-Cap Earnings, FOMC and Other Key Things to Watch this Week

Markets enter a pivotal week as President Trump abruptly canceled U.S. diplomatic travel to Pakistan for Iran talks, calling off the trip by Special Envoy Steve Witkoff and son-in-law Jared Kushner just as they prepared to depart for Islamabad. Trump's statement that "we have all the cards" and refusal to allow the "18 hour flight" signals hardening negotiating posture, while Iran's foreign minister departed Pakistan Friday after brief meetings with mediators, with Tehran reiterating it won't hold direct talks while the U.S. blockade of Iranian ports continues. The diplomatic stalemate intensifies energy market uncertainty heading into Wednesday's Federal Reserve meeting...

Fundamentals

See More
  • Market Capitalization, $K 185,948,464
  • Shares Outstanding, K 539,685
  • Annual Sales, $ 36,751 M
  • Annual Income, $ 7,711 M
  • EBIT $ 9,080 M
  • EBITDA $ 15,447 M
  • 60-Month Beta 0.47
  • Price/Sales 5.12
  • Price/Cash Flow 10.31
  • Price/Book 21.68

Options Overview Details

View History
  • Implied Volatility 33.61% (+0.17%)
  • Historical Volatility 18.78%
  • IV Percentile 92%
  • IV Rank 68.58%
  • IV High 39.99% on 05/28/25
  • IV Low 19.66% on 08/15/25
  • Expected Move (DTE 4) 14.81 (4.30%)
  • Put/Call Vol Ratio 0.08
  • Today's Volume 15,631
  • Volume Avg (30-Day) 5,379
  • Put/Call OI Ratio 0.89
  • Today's Open Interest 93,900
  • Open Int (30-Day) 95,908
  • Expected Range 329.74 to 359.36

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 36 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $4.73
  • Number of Estimates 12
  • High Estimate $5.19
  • Low Estimate $4.34
  • Prior Year $4.90
  • Growth Rate Est. (year over year) -3.47%

Price Performance

See More
Period Period Low Period High Performance
1-Month
335.06 +2.34%
on 04/07/26
359.45 -4.60%
on 04/09/26
-5.87 (-1.68%)
since 03/27/26
3-Month
335.06 +2.34%
on 04/07/26
391.29 -12.37%
on 03/02/26
-8.42 (-2.40%)
since 01/27/26
52-Week
261.43 +31.16%
on 05/14/25
391.29 -12.37%
on 03/02/26
+62.06 (+22.10%)
since 04/25/25

Most Recent Stories

More News
2 Profitable Stocks with Competitive Advantages and 1 Facing Headwinds

2 Profitable Stocks with Competitive Advantages and 1 Facing Headwinds

TEN : 39.21 (-0.15%)
UBER : 76.38 (+2.33%)
AMGN : 347.28 (+0.79%)
Mega-Cap Earnings, FOMC and Other Key Things to Watch this Week

Markets enter a pivotal week with key Mega-Cap earnings and Fed policy the main tings to watch along with any news from Iran.

META : 676.90 (+0.28%)
GOOGL : 345.58 (+0.34%)
AAPL : 267.40 (-1.35%)
CVX : 186.95 (+0.94%)
KO : 76.25 (-0.50%)
F : 12.55 (+1.37%)
GM : 78.00 (-0.06%)
MRK : 112.65 (+0.67%)
AMGN : 347.28 (+0.79%)
BMY : 58.88 (+0.29%)
MSFT : 420.17 (-1.05%)
SBUX : 98.93 (+0.26%)
AMGEN ANNOUNCES WEBCAST OF 2026 FIRST QUARTER FINANCIAL RESULTS

THOUSAND OAKS, Calif. , April 24, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its first quarter 2026 financial results on Thursday, April 30, 2026, after the close...

AMGN : 347.28 (+0.79%)
AMGEN ANNOUNCES RETIREMENT OF DAVID M. REESE, EXECUTIVE VICE PRESIDENT AND CHIEF TECHNOLOGY OFFICER

Organizational Changes Further Emphasize Integration of Biology and Technology

AMGN : 347.28 (+0.79%)
What to Expect From Amgen's Next Quarterly Earnings Report

Amgen is scheduled to report its first-quarter results next week, and analysts expect a single-digit earnings dip.

XLV : 144.87 (+0.48%)
$SPX : 7,165.08 (+0.80%)
AMGN : 347.28 (+0.79%)
2 S&P 500 Stocks Worth Your Attention and 1 We Ignore

2 S&P 500 Stocks Worth Your Attention and 1 We Ignore

DGX : 196.48 (+0.11%)
LRCX : 262.75 (-1.88%)
AMGN : 347.28 (+0.79%)
2 Dow Jones Stocks with Exciting Potential and 1 Facing Headwinds

2 Dow Jones Stocks with Exciting Potential and 1 Facing Headwinds

NKE : 45.32 (+1.41%)
AMGN : 347.28 (+0.79%)
MCD : 295.90 (-1.16%)
2 Reasons to Like AMGN and 1 to Stay Skeptical

2 Reasons to Like AMGN and 1 to Stay Skeptical

AMGN : 347.28 (+0.79%)
AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 3 RESULTS FOR SUBCUTANEOUS TEPEZZA® IN ADULTS LIVING WITH MODERATE-TO-SEVERE ACTIVE THYROID EYE DISEASE

Primary and Key Secondary Endpoints Met

AMGN : 347.28 (+0.79%)
Zai Lab Announces Global Clinical Trial Collaboration and Supply Agreement to Evaluate Novel DLL3 ADC, Zocilurtatug Pelitecan, in Combination with a Bispecific T-cell Engager Therapy

- Collaboration with Amgen to explore the clinical potential of Zai Lab’s DLL3-targeting ADC, zocilurtatug pelitecan, in combination with Amgen’s IMDELLTRA ® ...

ZLAB : 22.53 (-1.05%)
AMGN : 347.28 (+0.79%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Amgen Inc. is the leading biotech companies world wide, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health & nephrology and neuroscience markets. It developed two most successful drugs, Epogen & Neupogen. Amgen successfully launched two...

See More

Key Turning Points

3rd Resistance Point 352.44
2nd Resistance Point 350.05
1st Resistance Point 347.30
Last Price 347.28
1st Support Level 342.16
2nd Support Level 339.77
3rd Support Level 337.02

See More

52-Week High 391.29
Last Price 347.28
Fibonacci 61.8% 341.68
Fibonacci 50% 326.36
Fibonacci 38.2% 311.04
52-Week Low 261.43

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.